POCT National Diagnostics Forum

In 2008 Sarah began my career in Clinical Biochemistry at Leeds Teaching Hospitals. Having completed her initial training and passed by ACS assessment, in 2012 she joined the Clinical Biochemistry team at Bradford Royal Infirmary as a Senior Clinical Biochemist.

Throughout her career as a Clinical Biochemist she has had a particular interest in point of care testing (POCT) service. During her time working in Bradford Royal Infirmary she was responsible for several POCT services, including cardiac marker testing and the implementation of urinalysis meters throughout the Trust. 

In 2014 after gaining FRCPath, Sarah moved to Harrogate as a principal clinical Biochemist and took on the role of clinical lead for point of care testing. In 2017 she became a Consultant Clinical Biochemist. During her time at Harrogate time the Department has expanded, implementing additional services and taking on responsibility for community glucose and ketone testing.

In 2016 the Point of Care Testing Department at HDFT became the first in the UK to achieve UKAS accreditation to ISO15189 and 22870 for many aspects of the service, within the hospital, at outreach clinics and even in patient’s homes. Sarah has successfully led the Department through numerous UKAS surveillance visits and a second full assessment visit, including several extensions to scope.

Sarah is passionate about ensuring point of care testing is fully embedded in the patient pathway and is used in a clinical and cost effective way. Whilst the ISO standards (15189 and 22870) provide an excellent basis for developing high quality POCT services, she believes close clinical liaison is essential to integrate point of care testing with the Trust’s culture.

Katie Moss is the Greater Manchester Diagnostic Network Programme Director with over 24 years’ experience of working within various NHS diagnostic and senior management roles and is now responsible for leading and directing the portfolio of the Greater Manchester Diagnostic Network.

After graduating with a 2:1 BSc in Biomedical Science, Katie was appointed as an NHS Trainee Biomedical Scientist where she worked and specialised in Microbiology for over 14 years.  In that time, Katie went onto to complete a master’s in biomedical science and management Training Certificate before deciding upon a change of career.  Katie went on to successfully undertake roles within Clinical Audit, Transformation and Programme Management whilst developing her educational achievements with the completion of various programme management and leadership qualifications.

Katie is now an influential and highly recognised member of the NHS diagnostic community who has proven experience of delivering complex transformation programmes, establishing multi stakeholder networks including the establishment of both the Greater Manchester Imaging and Pathology Networks and developing short- and long-term strategic business models. 

Katie has a strong passion for diagnostic innovation and improving patient care through the adoption of new technologies and out of hospital diagnostics which support faster, real-time diagnosis and enable patients to have a greater ability to manage their own health and wellbeing.

Katie is the current chair of the Northwest Point of Care Strategy Group and is also responsible for leading the establishment of the Greater Manchester Physiological Sciences Network.

Outside of work, Katie is a mum to one, wife to one and dog parent to two bonkers spaniels.  She often spends her down time, walking the dogs, playing netball and being a real foodie, she loves to eat out and experience different cuisine.

Jayne first qualified in November 2000 as Haematology MLSO and started her Point of Care journey with INR’s in the community. Today she is the Point of Care manager for Diagnostic Laboratories at NHS Tayside on the east coast of Scotland, a post she has held since July 2020. Her remit is to provide laboratory oversight and mitigate risk within POC schemes ensuring that results can be used confidently in effective and efficient patient management pathways. This includes schemes both within hospital environments and the community, encompassing laboratory diagnostic specialities of Haematology, Biochemistry and Virology.

She co-founded POCT – FOR – SCOT LTD which is a website / Instagram / Face book community to share learning, provide support and push for regulation and strategic developments of point of care.  

Jayne is an advocate for ensuring Point of Care is used in the correct environment with innovative and effective patient management pathways that allow the right result to be used for positive patient gain. She champion’s this throughout her trust and the wider Scottish network.

Jayne currently sits of the specialist advisory panel for point of care at the IBMS and is part of a short life working group in Scotland advocating for point of care with strong policies and strategic goals to support the frail infrastructure of a NHS requiring innovation to survive the future.

At the John Radcliffe Hospital in Oxford Ian’s role was best be described as managing laboratory services in 3 areas:

• Screening: Newborn bloodspot and fetal anomaly screening programmes for the Thames Valley area.
• Mass spectrometry:  Regional Immunosuppressive drug monitoring service. 
• Point of Care Testing: Leading for the OUH Trust and working with Oxford Health in the community.  

Ian has been involved with Point of Care Testing for around 18 years and his POCT projects include: 

• Integration of the i-Stat into the OUH Trust for multiple point-of-care applications.
• Introduction of data-networked point of care testing in community hospitals. 
• Introduction of data-networked urine analysers across the Trust. 
• Development of a clinic-based point-of-care HBA1C service.
• Implementing Point-of-care CRP testing.
• Evaluation of the i-Stat BhCG application for use in an Early Pregnancy Assessment Unit.

Ian is a Public Health England Peer Assessor for UK National Screening Committee/NHS Screening Programmes; a Laboratory Advisor to Fetal Anomaly Screening Programme and a UKAS technical assessor.

He is also a Guest Lecturer on the Oxford Brookes University Biomedical Science degree course.

Ian joined Veritie Group in 2023. 

Currently based at Oxford University Hospitals NHS Foundation Trust. For over 15 years worked in Clinical Biochemistry, across sections of the laboratory. Appointed as Ian’s successor in 2022, managing laboratory services across antenatal and new-born screening; mass spectrometry, and Point of Care Testing (POCT).